APOE is a key gene in lipid metabolism and Alzheimer's disease. The main variants are ε2, ε3, and ε4. ε4 increases risk for late-onset Alzheimer's (OR 3–4 for heterozygotes, ~12 for homozygotes) and is linked to higher LDL cholesterol. ε2 may be protective but also associated with hypertriglyceridemia. Important: APOE is a risk factor, not a diagnosis. Many ε4 carriers never develop Alzheimer's. The evidence for personalized nutrition is limited: studies on low-fat diets show mixed results. A genetic test alone is insufficient for clinical decisions. Family history, lifestyle, and medical guidance are crucial. Commercial tests often overstate the impact of single SNPs. Evidence: strong for Alzheimer's association, moderate for dietary effects.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-e8ea7b852c2bd2d26ed3f0a8